Medicine and Dentistry
Infection
95%
Acinetobacter Baumannii
91%
Colistimethate
87%
Tigecycline
63%
Bacteremia
58%
Pathogen
43%
Healthcare Associated Infection
42%
Intensive Care Unit
41%
Mortality Rate
36%
Combination Therapy
32%
Antibiotics
29%
Pneumocystis Jirovecii
28%
Caspofungin
28%
Acute Heart Infarction
28%
Therapy Resistance
28%
Elizabethkingia Meningoseptica
28%
Disinfectant Agent
28%
Spectroscopy
28%
Chryseobacterium indologenes
28%
Salvage Therapy
28%
Lemierre's Syndrome
28%
Antibiotic Resistance
28%
Hemagglutinin
28%
Urinary Tract Infection
28%
Influenza Vaccine
28%
Immunogenicity
28%
Cell Culture
28%
Influenza A Virus (H7N9)
28%
Open-Label Trial
28%
Urinary Catheterization
28%
Urinary System
28%
Patient with Diabetes
28%
Hospital Mortality
26%
Antibiogram
25%
Medical Record
22%
Sepsis
18%
Cardiac Troponin
14%
Troponin I
14%
Fomite
14%
Low Drug Dose
14%
Drug Megadose
14%
Long-Term Care
14%
Artificial Respiration
14%
Clinician
14%
Multidrug Resistance
14%
Trimethoprim/Sulfamethoxazole
14%
Prevalence
14%
Adverse Event
13%
Piperacillin/Tazobactam
11%
Quinolone Derivative
11%
Pharmacology, Toxicology and Pharmaceutical Science
Infection
100%
Acinetobacter Baumannii
91%
Colistimethate
73%
Sepsis
59%
Bacteremia
56%
Tigecycline
48%
Infectious Agent
43%
Respiratory Tract
33%
Mortality Rate
29%
Acute Heart Infarction
28%
Nanomaterial
28%
Liquid Crystal
28%
Drug Delivery System
28%
Chlamydiae
28%
Breast Cancer
28%
Chryseobacterium indologenes
28%
Elizabethkingia Meningoseptica
28%
Healthcare Associated Infection
28%
Therapy Resistance
28%
Antibiotic Resistance
28%
Urinary Tract Infection
28%
Doxycycline
28%
Lemierre's Syndrome
28%
Azithromycin
28%
Hemagglutinin
28%
Normal Human
28%
Immunogenicity
28%
Influenza Vaccine
28%
Influenza A Virus (H7N9)
28%
Open-Label Trial
28%
Cell Culture
28%
Acinetobacter
28%
Antiinfective Agent
24%
Antibiotics
22%
Hospital Mortality
19%
Randomized Controlled Trial
18%
Combination Therapy
17%
Antibiotic Agent
15%
Comorbidity
14%
Prevalence
14%
Cotrimoxazole
14%
Adverse Event
13%
Disease
13%
Troponin I
11%
Quinolone Derivative
10%
Piperacillin Plus Tazobactam
10%
Bloodstream Infection
9%
Observational Study
9%
Chlamydiasis
9%
Pharyngitis
8%
Immunology and Microbiology
Infectious Agent
49%
Antibiotic Sensitivity
35%
Cryptococcus neoformans
28%
Rhodotorula
28%
Trichosporon
28%
Liquid Crystal
28%
Corynebacterium striatum
28%
Chlamydiae
28%
Chryseobacterium indologenes
28%
Elizabethkingia Meningoseptica
28%
Immunocompetent Cell
28%
Influenza A Virus (H7N9)
28%
COVID-19
28%
International Classification of Diseases
28%
Normal Human
28%
Immunogenicity
28%
Colistin
28%
Influenza Vaccine
28%
Hemagglutinin
28%
Cell Culture
28%
Immunoassay
28%
Bacterial Load
28%
Immune Complex
22%
Immune Response
22%
Medline
21%
Vaccine Efficacy
16%
Chlorhexidine
14%
Surface Property
14%
Random Amplified Polymorphic DNA
14%
Mortality Rate
14%
Solution and Solubility
14%
Hemodialysis
14%
Prevalence
14%
Awareness
14%
Fomite
11%
Multidrug Resistance
11%
Titer
8%
Seroconversion
8%
down Regulation
7%
Infectious Disease
7%
Immune System
7%
Peripheral Blood Mononuclear Cell
7%
Infection Sensitivity
7%
Cochrane Library
7%
Web of Science
7%
Upregulation
7%
CD4
7%
Natural Killer Cell
7%
Chlamydia Trachomatis
7%
Comorbidity
7%